conducted a study to analyze the infectious disease landscape and scope for areas of opportunities for drug development, product marketing, and physician education. HRA®
found an underserved stakeholder, infectious disease specialists. This syndicated study surveyed infectious disease specialists to strategically guide your entrance into the market and effectively target this audience.
In this study, HRA®
- Which infectious diseases physicians feel they are least equipped to handle
- Where physicians receive information on these diseases
- Factors contributing to issues with treating these diseases
- What drugs are currently available or in development to treat these diseases
- Likelihood to trying new drugs to treat these diseases